These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

693 related items for PubMed ID: 1829651

  • 1. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
    Suzuki H, Ikemoto M, Yokoyama A, Kamitani T, Yamashita N, Maruyama M, Yano S.
    Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
    [Abstract] [Full Text] [Related]

  • 2. Lysis of murine macrophages by lymphokine-activated killer-like cells induced by BCG in vitro.
    Chen MF, Suzuki H, Yano S.
    Microbiol Immunol; 1991 Jan; 35(7):557-67. PubMed ID: 1784257
    [Abstract] [Full Text] [Related]

  • 3. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R, Albi N, Zarcone D, Grossi CE, Velardi A.
    Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
    [Abstract] [Full Text] [Related]

  • 4. Non-MHC-restricted target-cell lysis by a CD4-CD8- TCR alpha beta T-cell line, as well as by TCR gamma delta T-cell lines, results from lymphokine-activated killing.
    Maziarz RT, Groh V, Prendergast M, Fabbi M, Strominger JL, Burakoff SJ.
    Int J Cancer; 1991 Apr 22; 48(1):142-7. PubMed ID: 1902200
    [Abstract] [Full Text] [Related]

  • 5. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
    Moretta A, Bottino C, Pende D, Tripodi G, Tambussi G, Viale O, Orengo A, Barbaresi M, Merli A, Ciccone E.
    J Exp Med; 1990 Dec 01; 172(6):1589-98. PubMed ID: 2147946
    [Abstract] [Full Text] [Related]

  • 6. Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules.
    Rivas A, Koide J, Laus R, Engleman EG.
    J Immunol; 1990 Jul 15; 145(2):470-6. PubMed ID: 2142178
    [Abstract] [Full Text] [Related]

  • 7. The role of T cell receptors in non-MHC-restricted cytotoxicity.
    Lauzon RJ, Siminovitch KA, Roder JC.
    Cell Immunol; 1989 Feb 15; 118(2):265-84. PubMed ID: 2521308
    [Abstract] [Full Text] [Related]

  • 8. Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations.
    Stanková J, Hoskin DW, Roder JC.
    Cell Immunol; 1989 Jun 15; 121(1):13-29. PubMed ID: 2470516
    [Abstract] [Full Text] [Related]

  • 9. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S, Cambiaggi A, Meazza R, Sforzini S, Marciano S, Mingari MC, Moretta L.
    Eur J Immunol; 1994 Oct 15; 24(10):2294-8. PubMed ID: 7925558
    [Abstract] [Full Text] [Related]

  • 10. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
    Zarcone D, Viale O, Cerruti G, Tenca C, Malorni W, Arancia G, Iosi F, Galandrini R, Velardi A, Moretta A.
    Cell Immunol; 1992 Sep 15; 143(2):389-404. PubMed ID: 1380897
    [Abstract] [Full Text] [Related]

  • 11. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
    Watanabe H, Narumi K, Stewart CC, Arbuck SG, Foon KA, Goldrosen MH.
    Anticancer Res; 1992 Sep 15; 12(6B):1925-33. PubMed ID: 1295440
    [Abstract] [Full Text] [Related]

  • 12. Lymphokine-activated killer (LAK) cells. VI. NK1.1+, CD3+ LAK effectors are derived from CD4-, CD8-, NK1.1- precursors.
    Ballas ZK, Rasmussen W.
    Cell Immunol; 1991 May 15; 134(2):296-313. PubMed ID: 1827045
    [Abstract] [Full Text] [Related]

  • 13. LD1: a CD4-CD8- TCR alpha beta/CD3+ peripheral T cell line with helper function for B lymphocytes.
    Pelkonen J, Palacios R.
    Int Immunol; 1990 May 15; 2(6):555-62. PubMed ID: 2150761
    [Abstract] [Full Text] [Related]

  • 14. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL, Roozemond RC, van de Griend RJ.
    J Immunol; 1986 Jun 01; 136(11):3939-44. PubMed ID: 3084649
    [Abstract] [Full Text] [Related]

  • 15. Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.
    de Vries JE, Yssel H, Spits H.
    Immunol Rev; 1989 Jun 01; 109():119-41. PubMed ID: 2527803
    [Abstract] [Full Text] [Related]

  • 16. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.
    Anderson PM, Blazar BR, Bach FH, Ochoa AC.
    J Immunol; 1989 Feb 15; 142(4):1383-94. PubMed ID: 2521662
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxic T lymphocyte triggering via CD16 is regulated by CD3 and CD8 antigens. Studies with T cell receptor (TCR)-alpha beta+/CD3+16+ and TCR-gamma delta+/CD3+16+ granular lymphocytes.
    Oshimi K, Oshimi Y, Yamada O, Wada M, Hara T, Mizoguchi H.
    J Immunol; 1990 May 01; 144(9):3312-7. PubMed ID: 2139452
    [Abstract] [Full Text] [Related]

  • 18. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
    van de Griend RJ, Bolhuis RL, Stoter G, Roozemond RC.
    J Immunol; 1987 May 15; 138(10):3137-44. PubMed ID: 2952709
    [Abstract] [Full Text] [Related]

  • 19. Evidence for quantitative and qualitative differences in functional activation of Mls-reactive T cell clones and hybridomas by antigen or TcR/CD3 antibodies.
    Gaugler B, Langlet C, Martin JM, Schmitt-Verhulst AM, Guimezanes A.
    Eur J Immunol; 1991 Oct 15; 21(10):2581-9. PubMed ID: 1680703
    [Abstract] [Full Text] [Related]

  • 20. Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cells.
    Cron RQ, Gajewski TF, Sharrow SO, Fitch FW, Matis LA, Bluestone JA.
    J Immunol; 1989 Jun 01; 142(11):3754-62. PubMed ID: 2523934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.